Mia Health Holdings <7129> announced its consolidated financial results for the second quarter of the fiscal year ending in March 2025 (April-September 24), with revenue increasing by 4.6% year-on-year to 11.498 billion yen, operating profit increasing by 399.8% to 0.124 billion yen, ordinary profit increasing by 494.0% to 0.12 billion yen, and net income attributable to parent company shareholders reaching 0.111 billion yen (compared to a loss of 0.032 billion yen in the same period last year).

Revenue from the pharmaceutical business increased by 3.6% year-on-year to 4.711 billion yen, with segment profit up by 9.3% to 0.265 billion yen. During the interim consolidated accounting period, one medical mall-type pharmacy was opened in July 2024 (Tachikawa City, Tokyo). The prescription volume increased by 105.1% compared to the previous year, driven by the effect of new stores opened in the previous and current accounting periods. Efforts to enhance services as a designated pharmacy and to secure technician fees minimized the impact of the dispensing fee and drug price revisions. The number of pharmacies at the end of the interim period was 43 stores (+1 store compared to the end of the previous accounting year).

Revenue from the child care support business increased by 3.7% year-on-year to 4.571 billion yen, with segment profit up by 12.7% to 0.364 billion yen. During the interim consolidated accounting period, one licensed nursery and one school-age club were opened. While the number of children in existing nurseries decreased, the opening of a licensed nursery in April 2023 and a school-age club in April 2024 contributed to performance. Efforts were made to secure appropriate staffing levels, and cost-effectiveness improved due to the closure of unprofitable nurseries in March 2024. The number of operational facilities at the end of the interim period was 79 facilities (+2 compared to the end of the previous accounting year).

Revenue from the elderly care business increased by 10.4% to 1.771 billion yen, with segment loss at 0.21 billion yen (compared to a loss of 0.085 billion yen in the same period last year). The utilization of the service-oriented elderly residence 'Hospice-compatible Homes (61 residents)' opened in August 2023 increased, along with continued sales efforts to attract residents and users, resulting in increased occupancy rates and revenue. The closure of unprofitable facilities in the previous accounting year contributed to improved cost-effectiveness and reduced the deficit. The number of care facilities at the end of the interim period was 65 facilities (no change compared to the end of the previous accounting year).

Revenue from other (food business) increased by 3.1% year-on-year to 0.443 billion yen, with segment profit up by 65.4% to 0.009 billion yen. The performance of the school meal department was sluggish due to price increases. The performance of Gin no Sara (3 stores), operated by the company as a franchisee, remained solid despite a decrease in customer numbers due to a decline in home delivery food demand, offset by an increase in customer unit prices reflecting price revisions due to inflation.

The consolidated performance forecast for the full fiscal year ending in March 2025 includes revenue of 22.9 billion yen, up 0.8% from the previous year, operating profit of 0.49 billion yen, a 24.0% increase, ordinary profit of 0.48 billion yen, a 28.3% increase, and net income attributable to parent company shareholders of 0.29 billion yen, in line with the initial plan.